Jeffrey Lieberman, M.D.

Psychiatry Columbia University, New York, NY 
"Jeffrey Lieberman"
Mean distance: 106866
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Trubetskoy V, Pardiñas AF, Qi T, et al. (2022) Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature
Stone WS, Phillips MR, Yang LH, et al. (2022) Neurodegenerative model of schizophrenia: Growing evidence to support a revisit. Schizophrenia Research. 243: 154-162
Zoghbi AW, Dhindsa RS, Goldberg TE, et al. (2021) High-impact rare genetic variants in severe schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 118
Paul SM, Breier A, Lieberman JA, et al. (2021) Clinical Trial of New Drug for Schizophrenia. Reply. The New England Journal of Medicine. 384: e105
Stone WS, Cai B, Liu X, et al. (2020) Association Between the Duration of Untreated Psychosis and Selective Cognitive Performance in Community-Dwelling Individuals With Chronic Untreated Schizophrenia in Rural China. Jama Psychiatry
Maes MS, Lu JY, Tiwari AK, et al. (2020) Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia. Drug Development Research
Kantrowitz JT, Javitt DC, Freedman R, et al. (2020) Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Clelland CL, Kantrowitz JT, Choo T, et al. (2020) Adjunctive sapropterin dihydrochloride treatment in schizophrenia: A positive proof-of-concept, rater-blind, randomized, multivitamin-controlled study. Schizophrenia Research
Correll CU, Davis RE, Weingart M, et al. (2020) Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial. Jama Psychiatry
Yoshida K, Maciukiewicz M, Marshe V, et al. (2020) M172. POLYGENIC RISK SCORES ANALYSES IN ANTIPSYCHOTIC-INDUCED WEIGHT GAIN Schizophrenia Bulletin. 46: S202-S202
See more...